Clinical Study
Relative Prognostic Value of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Operable Oesophagogastric Cancer
Table 3
Univariate analysis of factors associated with duration of survival.
| Factor | | df | P value |
| HER2 overexpression | 1.497 | 1 | 0.221 | pT stage | 17.346 | 3 | 0.001 | Age | 68.826 | 4 | 0.001 | pN stage | 34.272 | 3 | <0.0001 | pTNM stage | 30.786 | 3 | <0.0001 | Lymph node ratio | 183.926 | 3 | <0.0001 |
|
|